• bitcoinBitcoin(BTC)$62,530.00-0.18%
  • ethereumEthereum(ETH)$1,772.760.91%
  • tetherTether(USDT)$1.00-0.01%
  • binancecoinBNB(BNB)$584.270.97%
  • usd-coinUSDC(USDC)$1.000.00%
  • rippleXRP(XRP)$0.97-0.19%
  • solanaSolana(SOL)$73.580.58%
  • tronTRON(TRX)$0.3104180.50%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.042.75%
  • HyperliquidHyperliquid(HYPE)$67.831.24%
  • zcashZcash(ZEC)$902.07-0.82%
  • moneroMonero(XMR)$494.22-0.73%
  • dogecoinDogecoin(DOGE)$0.058664-0.31%
  • leo-tokenLEO Token(LEO)$9.30-0.08%
  • whitebitWhiteBIT Coin(WBT)$60.660.06%
  • chainlinkChainlink(LINK)$9.050.03%
  • USDSUSDS(USDS)$1.00-0.01%
  • cardanoCardano(ADA)$0.1530440.87%
  • Ethena USDeEthena USDe(USDE)$1.000.02%
  • stellarStellar(XLM)$0.133338-3.17%
  • daiDai(DAI)$1.00-0.02%
  • nearNEAR Protocol(NEAR)$3.281.18%
  • bitcoin-cashBitcoin Cash(BCH)$207.890.50%
  • litecoinLitecoin(LTC)$42.90-2.02%
  • RainRain(RAIN)$0.0046041.05%
  • CantonCanton(CC)$0.081348-0.17%
  • avalanche-2Avalanche(AVAX)$7.031.14%
  • uniswapUniswap(UNI)$5.04-2.57%
  • tether-goldTether Gold(XAUT)$3,666.26-1.31%
  • suiSui(SUI)$0.72-0.40%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.030.76%
  • USD1USD1(USD1)$1.000.02%
  • Ripple USDRipple USD(RLUSD)$1.00-0.01%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • hedera-hashgraphHedera(HBAR)$0.054893-1.17%
  • paypal-usdPayPal USD(PYUSD)$1.000.00%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.09%
  • BittensorBittensor(TAO)$194.851.88%
  • shiba-inuShiba Inu(SHIB)$0.0000041.23%
  • quant-networkQuant(QNT)$150.58-0.54%
  • crypto-com-chainCronos(CRO)$0.041512-2.50%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.120.11%
  • MemeCoreMemeCore(M)$0.84-6.11%
  • okbOKB(OKB)$86.670.59%
  • Falcon USDFalcon USD(USDF)$1.000.03%
  • pax-goldPAX Gold(PAXG)$3,665.37-1.36%
  • United StablesUnited Stables(U)$1.000.03%
  • aaveAave(AAVE)$105.38-2.08%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Palvella Therapeutics, Inc. (PVLA) Discusses QTORIN Docetaxel for Extramammary Pagets Disease Prepared Remarks Transcript

November 19, 2026
in Market & News
Reading Time: 2 mins read
A A
Palvella Therapeutics, Inc. (PVLA) Discusses QTORIN Docetaxel for Extramammary Pagets Disease Prepared Remarks Transcript
ShareShareShareShareShare

Operator

Good day, and thank you for standing by. Welcome to the QTORIN docetaxel for Extramammary Paget’s Disease Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.

YOU MAY ALSO LIKE

Susan Smith is denied parole again 32 years after drowning her sons in a South Carolina lake – AP News

Warner Music Group Corp. (WMG) Q4 2026 Earnings Call Transcript

I would now like to hand the conference over to your speaker today, Bohan Wei, Vice President of Corporate Development and New Product Planning. Please go ahead.

Bohan Wei
Vice President of Corporate Development & New Product Planning

Thank you, operator. Good morning, and thank you for joining the Palvella Therapeutics conference call to discuss our new product candidate, QTORIN docetaxel for Extramammary Paget’s Disease. As a reminder, our press release detailing today’s announcements can be found in the Investors section of our website at www.palvellatx.com.

Before we begin, please note that today’s remarks may include forward-looking statements regarding our development programs, regulatory strategy, commercial planning and financial outlook. These statements are based on current assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Please refer to our SEC filings for a full discussion of these risk factors.

The format of today’s conference call will be presentation only. Additionally, as a reminder, we will not be discussing or commenting on our ongoing clinical trials.

On today’s call, we are joined by Wes Kaupinen, Palvella’s Founder and Chief Executive Officer; Dr. Jeff Martini, our Chief Scientific Officer; Dr. David Osborne, our Chief Innovation Officer; Dr. Seemal Desai, Founder of Innovative Dermatology and Faculty at the University of Texas Southwestern Medical Center; and Steve Schroeder, an EMPD patient and founder

Credit: Source link

ShareTweetSendSharePin

Related Posts

Susan Smith is denied parole again 32 years after drowning her sons in a South Carolina lake – AP News
Market & News

Susan Smith is denied parole again 32 years after drowning her sons in a South Carolina lake – AP News

November 19, 2026
Warner Music Group Corp. (WMG) Q4 2026 Earnings Call Transcript
Market & News

Warner Music Group Corp. (WMG) Q4 2026 Earnings Call Transcript

November 19, 2026
Nvidia Looks Like A 0 Stock To Me, As Buy-And-Hold Becomes Buy-And Hope (NASDAQ:NVDA)
Market & News

Nvidia Looks Like A $100 Stock To Me, As Buy-And-Hold Becomes Buy-And Hope (NASDAQ:NVDA)

November 19, 2026
Danish lawmakers approve a security deal with Greenland and the US, hoping to finally end tensions – AP News
Market & News

Danish lawmakers approve a security deal with Greenland and the US, hoping to finally end tensions – AP News

November 19, 2026
Next Post
Apple Watch’s Always-Listening AI Features Provide Little Value

Apple Watch’s Always-Listening AI Features Provide Little Value

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
After Jensen Huang’s downfall, here’s an even bigger problem that threatens the AI industry

After Jensen Huang’s downfall, here’s an even bigger problem that threatens the AI industry

November 13, 2026
Whoop Humans Is A Social Network Designed For Fitness Enthusiasts

Whoop Humans Is A Social Network Designed For Fitness Enthusiasts

November 13, 2026
She’s Getting a 0,000 Inheritance and It’s a Secret

She’s Getting a $400,000 Inheritance and It’s a Secret

November 12, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!